Eva Wong

Eva Wong has a strong background in clinical research and trial management. Eva is currently working as a Global Clinical Operations Lead at Sarepta Therapeutics since 2021. Prior to that, they spent several years at Brigham and Women's Hospital, where they held roles such as Clinical Program Manager for Amyloidosis Research Program and Sr. Project/Clinical Trial Manager for Amyloidosis Research Program. During their time at Brigham and Women's Hospital, Eva made significant contributions to the successful FDA drug approvals for AMVUTTRA, Vyndaqel, and Vyndamax. Before joining Brigham and Women's Hospital, Eva worked as a Senior Clinical Research Coordinator for Adult Leukemia Program at Dana-Farber Cancer Institute, where they played a crucial role in the FDA approvals of Elzonris and Inotuzumab ozogamicin. Additionally, Eva had internships at VA Boston Healthcare System and Dana-Farber Cancer Institute, where they gained valuable experience as a Clinical Research Assistant and Clinical Research Coordinator, respectively.

Eva Wong earned a Bachelor of Applied Science (BASc) degree in Microbiology and Immunology from the University of Massachusetts Amherst. Additionally, they have obtained multiple certifications in various areas such as Productive Leadership, Executive Leadership, Leading with Intelligent Disobedience, and more from LinkedIn.